Related Experiment Video
Updated: Apr 26, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21
Marion Cornu1, Wolfgang Oppliger1, Verena Albert1
1Biozentrum, University of Basel, CH-4056 Basel, Switzerland;
Abstract:
The liver is a key metabolic organ that controls whole-body physiology in response to nutrient availability. Mammalian target of rapamycin (mTOR) is a nutrient-activated kinase and central controller of growth and metabolism that is negatively regulated by the tumor suppressor tuberous sclerosis complex 1 (TSC1). To investigate the role of hepatic mTOR complex 1 (mTORC1) in whole-body physiology, we generated liver-specific Tsc1 (L-Tsc1 KO) knockout mice. L-Tsc1 KO mice displayed reduced locomotor activity, body temperature, and hepatic triglyceride content in a rapamycin-sensitive manner. Ectopic activation of mTORC1 also caused depletion of hepatic and plasma glutamine, leading to peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α)-dependent fibroblast growth factor 21 (FGF21) expression in the liver. Injection of glutamine or knockdown of PGC-1α or FGF21 in the liver suppressed the behavioral and metabolic defects due to mTORC1 activation. Thus, mTORC1 in the liver controls whole-body physiology through PGC-1α and FGF21. Finally, mTORC1 signaling correlated with FGF21 expression in human liver tumors, suggesting that treatment of glutamine-addicted cancers with mTOR inhibitors might have beneficial effects at both the tumor and whole-body level.
Insights
Liver mTORC1 signaling controls whole-body physiology via PGC-1α and FGF21. This pathway
Area of Science:
- Metabolic regulation
- Molecular biology
- Physiology
Background:
- The liver is a central metabolic organ.
- Mammalian target of rapamycin (mTOR) regulates growth and metabolism.
- Tuberous sclerosis complex 1 (TSC1) negatively regulates mTOR.
Purpose of the Study:
- Investigate the role of liver-specific mTOR complex 1 (mTORC1) in whole-body physiology.
- Determine the molecular mechanisms linking hepatic mTORC1 to metabolic and behavioral phenotypes.
Main Methods:
- Generated liver-specific Tsc1 knockout (L-Tsc1 KO) mice.
- Administered rapamycin to assess pathway sensitivity.
- Performed glutamine injections and PGC-1α/FGF21 knockdown experiments.
Main Results:
- L-Tsc1 KO mice showed reduced activity, body temperature, and liver triglycerides.
- mTORC1 activation depleted hepatic and plasma glutamine.
- This led to PGC-1α-dependent FGF21 expression, causing metabolic and behavioral defects.
Conclusions:
- Hepatic mTORC1 signaling regulates whole-body physiology through PGC-1α and FGF21.
- mTORC1 signaling correlates with FGF21 in human liver tumors.
- mTOR inhibitors may benefit glutamine-addicted cancers.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Regulation of Metabolism
Regulation of Angiogenesis and Blood Supply
Thermoregulation

